- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma Progression in Mexico
Total 292 results
-
Instituto de Seguridad y Servicios Sociales de...UnknownRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma ProgressionMexico
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
Grupo Cooperativo de Hemopatías MalignasWithdrawn
-
Hospital Universitario Dr. Jose E. GonzalezCompletedLymphoma | Myeloma MultipleMexico
-
Grupo Cooperativo de Hemopatías MalignasRecruitingChronic Myeloid Leukaemia Recurrent | Chronic Myeloid Leukemia, in RelapseMexico
-
Hoffmann-La RocheActive, not recruitingProgressive Multiple Sclerosis (PMS)United States, Canada, Brazil, France, Netherlands, Ireland, Germany, Italy, Poland, Russian Federation, Spain, Colombia, Morocco, Hungary, Denmark, Lebanon, Mexico, Costa Rica, Bosnia and Herzegovina, Czechia, Egypt, Guatemala, Panama and more
-
Grupo Cooperativo de Hemopatías MalignasWithdrawnAcute Myeloid Leukemia | Myelodysplastic SyndromesMexico
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
National Institute of Allergy and Infectious Diseases...Novartis Pharmaceuticals; Autoimmunity Centers of ExcellenceCompletedSecondary Progressive Multiple SclerosisUnited States
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Brazil, Poland, United Kingdom, Turkey, Bulgaria, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Mexico, Argentina
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, United Kingdom, Hungary, Bulgaria, Puerto Rico, Poland, Argentina, Brazil, Germany, Greece, Italy, Peru, Portugal, Russian Federation, Spain, Turkey, Ukraine, Israel, France, Switzerland, Colombia, Me... and more
-
Hospital General de MexicoFresenius KabiUnknownAcute Myeloid Leukemia, AdultMexico
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
Immunic AGActive, not recruitingMultiple SclerosisUnited States, Germany, Netherlands, Bulgaria, Serbia, Canada, Czechia, Moldova, Republic of, North Macedonia, Poland, Romania, Ukraine
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
Hoffmann-La RocheRecruitingMultiple Sclerosis, Primary ProgressiveCanada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
-
Instituto Mexicano del Seguro SocialCompleted
-
Hospital General de MexicoRecruiting
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
-
Hospital General de MexicoUnknown
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
El Instituto Nacional de Neurologia y Neurocirugia...National Council of Science and Technology, MexicoCompleted
-
CelgeneCompletedLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Leukemia, Myelomonocytic, ChronicUnited States
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
Coordinación de Investigación en Salud, MexicoCompleted
-
Mexican Agrupation for Hematology StudyInstituto Mexicano del Seguro Social; Hospital Universitario Dr. Jose E. Gonzalez and other collaboratorsNot yet recruitingAcute Myeloid LeukemiaMexico
-
Instituto Nacional de Cancerologia de MexicoCompletedPromyelocytic Leukemia, AcuteMexico
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Japan, Bulgaria, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, Slo... and more
-
Universidad Nacional Autonoma de MexicoInstituto Nacional de Neurología y NeurocirugíaEnrolling by invitationMethylprednisolone | Intranasal Administration | Patients With an Active Multiple Sclerosis RelapseMexico
-
Novartis PharmaceuticalsApproved for marketing
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
PfizerCompletedNeoplasms | Multiple Myeloma | Lymphoma, Malignant | ThrombocytopeniaUnited States, Argentina, Mexico
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Poland, Taiwan, Korea, Republic of, Japan, United Kingdom, Brazil, Mexico, Turkey, Argentina
-
Hospital Universitario Dr. Jose E. GonzalezNovartis PharmaceuticalsCompletedLeukemia, Myeloid, Chronic, BCR-ABL PositiveMexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
Hospital Universitario Dr. Jose E. GonzalezFernando De la Garza SalazarRecruitingChronic Myeloid Leukemia, Chronic PhaseMexico
-
Instituto Jalisciense de CancerologiaUniversity of Guadalajara; Instituto Mexicano del Seguro SocialUnknownMultiple Sclerosis, Relapsing-RemittingMexico
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma | Amyloidosis | Waldenstrom's Macroglobulinemia | Monoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
Instituto Nacional de Ciencias Medicas y Nutricion...UnknownAcute Myeloid Leukemia | Acute Lymphoid LeukemiaMexico
-
National Institute of CancerologíaUnknownAcute Myeloblastic Leukemia | Acute Lymphoblastic Leukemia.Mexico
-
Janssen-Cilag Ltd.CompletedLymphoma | Leukemia | Multiple Myeloma | Non-Hodgkin | LymphoidArgentina, Colombia, Mexico, Panama, Brazil, Chile, Guatemala
-
FibroBiologicsCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingMexico
-
Hospital Universitario Dr. Jose E. GonzalezRecruitingPromyelocytic LeukemiaMexico
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
Hospital Universitario Dr. Jose E. GonzalezUnknownChronic Myelogenous LeukemiaMexico
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedLymphoma | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway